Nancy Bonifant Halstead

she/her/hers

Partner

“Nan is so incredibly skilled with her depth of knowledge in her own field. I feel I can go to her with any number of issues and she is very capable of giving me an incredible knowledge base from which to draw from.”

Chambers USA, Healthcare: Pharmaceutical/Medical Products Regulatory client

“Nan is so knowledgeable and so practical in her advice, which is really great. She understands the constraints of where we are. Her advice is always really practical and usable in my practice.”

Chambers USA, Healthcare: Pharmaceutical/Medical Products Regulatory client

“Nan is an outstanding attorney with exceptional depth in the evolving intersection of healthcare and technology. She has a rare ability to translate complex regulatory and reimbursement issues into clear, practical strategies that support innovation while managing risk.”

Chambers USA, Healthcare: Pharmaceutical/Medical Products Regulatory client

“Nan is absolutely terrific. She has deep expertise in all these areas and is the type of attorney you can call with an issue and she almost always has feedback for you on the spot based on her deep expertise. She is creative in positively finding solutions to issues.”

Chambers USA, Healthcare: Pharmaceutical/Medical Products Regulatory client

Nan is a health care regulatory attorney. Her practice lies at the convergence of health care and technology, where she provides comprehensive guidance to global medical device and technology companies on fraud and abuse, privacy, and reimbursement risks specific to digital health and innovative medical technologies that often challenge existing regulatory and reimbursement frameworks. Nan is recognized for her creative and practical risk management solutions, grounded in her extensive knowledge of the health care industry and her understanding of her clients’ businesses, operations, and objectives.

Experience

Representative matters

Advising certified EHR developer on 2015 Edition Cures Update to the ONC certification criteria, including the new Information Blocking Rule
Advising multi-state, non-profit health system on operational compliance strategies that incorporate the new Information Blocking Rule requirements
Advising medical device manufacturer on strategic development and commercialization agreements involving integrated medical devices, mobile health applications, and cloud-based disease management solutions

Recognitions

  • Ranked in Chambers USA for District of Columbia Healthcare: Pharmaceutical/Medical Products Regulatory, 2024-2026

Credentials

Education

  • University of Maryland School of Law, 2011, J.D., Order of the Coif, Maryland Law Review – Executive Symposium/Articles Editor; Health Law Certificate Recipient
  • Wake Forest University, 2008, B.A., Chemistry, magna cum laude; Phi Beta Kappa

Professional admissions & qualifications

  • District of Columbia
  • Maryland

Professional affiliations

  • American Health Lawyers Association

News

Media mentions

Blogs